JOSHUA HEALTHCARE STRATEGIES LTD

Executive Summary

Joshua Healthcare Strategies Ltd is an early-stage micro entity with minimal financial resources, no reported revenue, and limited operational scale. The company currently lacks the financial strength and liquidity to support credit facilities, resulting in a decline recommendation. Close monitoring of future trading performance and cash flow is essential before reconsidering credit support.

JOSHUA HEALTHCARE STRATEGIES LTD - Analysis Report

Company Number: 15085038

Analysis Date: 2025-07-29 19:38 UTC

1. Credit Opinion:
   DECLINE. Joshua Healthcare Strategies Ltd is a very newly incorporated company (August 2023) with minimal financial history and very limited operational scale. The latest abridged accounts show only £572 in cash and net current assets, with net liabilities of £572 reported (net assets negative in one section, but shareholders’ funds positive by £573, suggesting minor data inconsistency or rounding). The company has only one employee and minimal expenses recorded (£2,100 staff costs). There is no reported turnover or profit, indicating no trading activity or revenue generation to support debt servicing. Without meaningful revenues or positive cash flow, the company currently lacks capacity to service credit facilities. The director is also the sole shareholder with full control, which is positive from a management accountability perspective but does not mitigate the financial weakness.

2. Financial Strength:
   The balance sheet is extremely thin, reflecting a micro-sized entity with negligible assets and minimal equity. No fixed assets are reported, and current assets consist solely of a small cash balance. The net current assets are reported as £572, which is insufficient to cover any material liabilities. The company operates at a loss position per the profit and loss reserve, and shareholders’ funds are minimal. This lack of asset base and equity buffer signals very weak financial strength. The company may be relying on director funding or minimal external capital at this stage. There is no indication of reserves or retained earnings to absorb losses.

3. Cash Flow Assessment:
   Cash at bank is minimal (£572), indicating extremely limited liquidity. Given the lack of revenue and small cash reserves, working capital is tight and vulnerable to any unexpected expenses or delays in cash inflow. The company’s operating costs are low due to minimal staffing, but there is no evidence of positive operating cash flow. The absence of turnover suggests a reliance on initial capital injection or external financing. The company’s ability to meet short-term obligations or debt repayments is highly questionable at present.

4. Monitoring Points:

• Track generation of turnover and profitability in upcoming periods to assess ability to cover operating expenses and service debt.
• Monitor cash flow closely, particularly cash burn rate versus incoming receipts.
• Observe equity injections or external funding rounds to improve capital base.
• Review director’s continued financial support and management effectiveness in scaling operations.
• Watch for timely filing of accounts and confirmation statements to ensure compliance and transparency.